Uncategorized
Aerie Pharmaceuticals Announces Appointment of Thomas A. Shepard as Vice President, Implant Manufacturing
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye, today announced the appointment of Thomas A. Shepard as Vice President, Implant Manufacturing, reporting to Casey Kopczynski, Ph.D., Aerie’s Chief Scientific Officer. Mr. Shepard will lead Aerie’s